Inhaled Treprostinil and FVC Change in Patients With Interstitial Lung Disease and Associated Pulmonary Hypertension
Publication
, Journal Article
Nathan, SD; Waxman, A; Rajagopal, S; Case, A; Johri, S; DuBrock, H; Zerda, DDL; Sahay, S; King, C; Melendres-Groves, L; Smith, P; Shen, E ...
Duke Scholars
Citation
APA
Chicago
ICMJE
MLA
NLM
Nathan, S. D., Waxman, A., Rajagopal, S., Case, A., Johri, S., DuBrock, H., … Tapson, V. (n.d.). Inhaled Treprostinil and FVC Change in Patients With Interstitial Lung Disease and Associated Pulmonary Hypertension.
Nathan, Steven D., Aaron Waxman, Sudarshan Rajagopal, Amy Case, Shilpa Johri, Hilary DuBrock, David De La Zerda, et al. “Inhaled Treprostinil and FVC Change in Patients With Interstitial Lung Disease and Associated Pulmonary Hypertension,” n.d.
Nathan SD, Waxman A, Rajagopal S, Case A, Johri S, DuBrock H, et al. Inhaled Treprostinil and FVC Change in Patients With Interstitial Lung Disease and Associated Pulmonary Hypertension.
Nathan SD, Waxman A, Rajagopal S, Case A, Johri S, DuBrock H, Zerda DDL, Sahay S, King C, Melendres-Groves L, Smith P, Shen E, Edwards LD, Nelsen A, Tapson V. Inhaled Treprostinil and FVC Change in Patients With Interstitial Lung Disease and Associated Pulmonary Hypertension.